{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:58:53Z","timestamp":1787828333461,"version":"build-2784847793"},"reference-count":60,"publisher":"American Society for Clinical Investigation","issue":"20","funder":[{"DOI":"10.13039\/100000060","name":"The National Institute of Allergy and infectious Diseases","doi-asserted-by":"crossref","award":["RO1AI126596"],"award-info":[{"award-number":["RO1AI126596"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"The National Institute of Allergy and infectious Diseases","doi-asserted-by":"crossref","award":["RO1HL141815"],"award-info":[{"award-number":["RO1HL141815"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NPRP grant","award":["9-350-3-074"],"award-info":[{"award-number":["9-350-3-074"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,18]]},"abstract":"<jats:p>\n                    Recent studies in cancer research have focused intensely on the antineoplastic effects of immune checkpoint inhibitors. While the development of these inhibitors has progressed successfully, strategies to further improve their efficacy and reduce their toxicity are still needed. We hypothesized that the delivery of anti\u2013PD-1 antibody encapsulated in PLGA nanoparticles (anti\u2013PD-1 NPs) to the spleen would improve the antitumor effect of this agent. Unexpectedly, we found that mice treated with a high dose of anti\u2013PD-1 NPs exhibited significantly higher mortality compared with those treated with free anti\u2013PD-1 antibody, due to the overactivation of T cells. Administration of anti\u2013PD-1 NPs to splenectomized LT-\u03b1\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice, which lack both lymph nodes and spleen, resulted in a complete reversal of this increased mortality and revealed the importance of secondary lymphoid tissues in mediating anti\u2013PD-1\u2013associated toxicity. Attenuation of the anti\u2013PD-1 NPs dosage prevented toxicity and significantly improved its antitumor effect in the B16-F10 murine melanoma model. Furthermore, we found that anti\u2013PD-1 NPs undergo internalization by DCs in the spleen, leading to their maturation and the subsequent activation of T cells. Our findings provide important clues that can lead to the development of strategies to enhance the efficacy of immune checkpoint inhibitors.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.122700","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T11:01:49Z","timestamp":1539774109000},"source":"Crossref","is-referenced-by-count":64,"title":["Targeting antigen-presenting cells by anti\u2013PD-1 nanoparticles augments antitumor immunity"],"prefix":"10.1172","volume":"3","author":[{"given":"Farideh","family":"Ordikhani","sequence":"first","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Uehara","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-3466","authenticated-orcid":true,"given":"Vivek","family":"Kasinath","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siawosh K.","family":"Eskandari","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharak","family":"Bahmani","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Yonar","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil R.","family":"Azzi","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-7456","authenticated-orcid":true,"given":"Yousef","family":"Haik","sequence":"additional","affiliation":[{"name":"College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Sage","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Dermatopathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Masschusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-1202","authenticated-orcid":true,"given":"Nasim","family":"Annabi","sequence":"additional","affiliation":[{"name":"Department of chemical and Biomolecular Engineering, UCLA, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schatton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Guleria","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abdi","sequence":"additional","affiliation":[{"name":"Transplantation Research Center, Renal Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/ar567","article-title":"The instructive role of dendritic cells on T-cell responses","volume":"4 Suppl 3","author":"Sallusto","year":"2002","journal-title":"Arthritis Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2000.00888.x"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.03"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e328306117f"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02401.x"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017"},{"issue":"12","key":"B7","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1756287215597647"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.11.001"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709684"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.05.011"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.07.005"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad7118"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0329-9"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701044"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1074374"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.5b05030"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.01.044"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.062"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.04.002"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/nn5062029"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01830-8"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.010"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175202"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113744109"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.08.006"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature11260"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.061986"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.015"},{"issue":"4","key":"B30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.155.4.1685","article-title":"Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness","volume":"155","author":"Banks","year":"1995","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-016-0117-1","article-title":"Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study","volume":"4","author":"Koelzer","year":"2016","journal-title":"J Immunother Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2677"},{"issue":"389","key":"B33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3604","article-title":"In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2016.09.004"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.170"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-012-0027-4"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri1224"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(90)90011-P"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1989"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000802"},{"issue":"2","key":"B43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7150\/jbm.18877","article-title":"Nanoparticle Design Strategies for Effective Cancer Immunotherapy","volume":"2","author":"Velpurisiva","year":"2017","journal-title":"J Biomed (Syd)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3030662"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00109"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505197"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1320"},{"key":"B48","article-title":"PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.052"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.005"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.101"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0482"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.1.424"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.007"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080063"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.08.004"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.7.3797"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.022"},{"issue":"Suppl 4","key":"B60","first-page":"65","article-title":"Growth rate analysis and efficient experimental design for tumor xenograft studies","volume":"13","author":"Hather","year":"2014","journal-title":"Cancer Inform"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/122700\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:40:04Z","timestamp":1779194404000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/122700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":60,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2018,10,18]]},"published-print":{"date-parts":[[2018,10,18]]}},"alternative-id":["10.1172\/jci.insight.122700"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.122700","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"article-number":"e122700"}}